AgomAb Therapeutics NV (AGMB)
7.96
-0.44
(-5.24%)
USD |
NASDAQ |
Oct 28, 16:00
8.11
+0.15
(+1.88%)
After-Hours: 20:00
AgomAb Therapeutics Market Cap : 392.01M for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 392.01M |
| October 27, 2026 | 413.68M |
| October 26, 2026 | 422.06M |
| October 23, 2026 | 445.69M |
| October 22, 2026 | 456.04M |
| October 21, 2026 | 448.65M |
| October 20, 2026 | 429.94M |
| October 19, 2026 | 405.31M |
| October 16, 2026 | 407.77M |
| October 15, 2026 | 410.24M |
| October 14, 2026 | 427.97M |
| October 13, 2026 | 433.87M |
| October 12, 2026 | 447.66M |
| October 09, 2026 | 447.17M |
| October 08, 2026 | 454.07M |
| October 07, 2026 | 433.38M |
| October 06, 2026 | 435.35M |
| October 05, 2026 | 427.97M |
| October 02, 2026 | 421.56M |
| October 01, 2026 | 426.00M |
| September 30, 2026 | 546.65M |
| September 29, 2026 | 518.58M |
| September 28, 2026 | 502.82M |
| September 25, 2026 | 517.60M |
| September 24, 2026 | 521.04M |
| Date | Value |
|---|---|
| September 23, 2026 | 530.15M |
| September 22, 2026 | 565.86M |
| September 21, 2026 | 576.20M |
| September 18, 2026 | 599.35M |
| September 17, 2026 | 594.92M |
| September 16, 2026 | 561.92M |
| September 15, 2026 | 598.86M |
| September 14, 2026 | 604.77M |
| September 11, 2026 | 643.18M |
| September 10, 2026 | 686.52M |
| September 09, 2026 | 736.75M |
| September 08, 2026 | 734.29M |
| September 04, 2026 | 777.13M |
| September 03, 2026 | 730.35M |
| September 02, 2026 | 672.73M |
| September 01, 2026 | 666.82M |
| August 31, 2026 | 648.60M |
| August 28, 2026 | 648.60M |
| August 27, 2026 | 681.59M |
| August 26, 2026 | 703.26M |
| August 25, 2026 | 690.46M |
| August 24, 2026 | 631.36M |
| August 21, 2026 | 652.54M |
| August 20, 2026 | 661.40M |
| August 19, 2026 | 677.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 13.65M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Invion Ltd. | 4.030M |
| Arvinas, Inc. | 496.28M |
| Fulcrum Therapeutics, Inc. | 286.07M |
Market Cap Related Metrics
| Price | 7.96 |